Impel neuropharma headquarters
WitrynaFind real-time IMPL - Impel Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Witryna29 mar 2024 · The marks "IMPEL," "POD," "Trudhesa," "IMPELPOD" and the Impel NeuroPharma logo and our other registered or common law trade names, trademarks or service marks appearing in this report are the property of Impel. All other service marks, trademarks and trade names appearing in this report are the property of their …
Impel neuropharma headquarters
Did you know?
Witryna23 kwi 2024 · Impel NeuroPharma's headquarters is located at 201 Elliott Avenue West, Seattle. What is Impel NeuroPharma's latest funding round? Impel … WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high unmet medical needs. IMPEL, POD, Trudhesa, Trudhesa DIRECT, and the Impel and … Impel Pharmaceuticals’ mission is to create and provide transformative therapies for … Impel Pharmaceuticals has developed a proprietary drug delivery technology … The efficacy of currently approved DHE-based medications is well-established … Impel INP105 – Acute Treatment of Agitation and Aggression in Autism … Impel Pharmaceuticals is currently developing INP107, a non-invasive, self- … impel pharmaceuticals has developed its proprietary Precision Olfactory Delivery … Archive of posts categorized by Publications in Impel Pharmaceuticals. Impel … Impel attended the 2024 Headache Cooperative of the Pacific’s 14th Annual …
Witryna(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Adrian Adams President and Chief Executive Officer … Witryna9 lis 2024 · Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative therapies for people living with central nervous system (CNS) and other ...
Witryna12 kwi 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Impel Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for IMPL. The average twelve-month price prediction for Impel Pharmaceuticals is $21.25 with a high price target of $40.00 and a low price target of … Witryna3 wrz 2024 · About Impel NeuroPharma Impel NeuroPharma, Inc., is a privately-held, Seattle-based biopharmaceutical company devoted to creating life-changing, innovative therapies for central nervous system ...
Witryna15 lis 2024 · Impel NeuroPharma, Inc. is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with …
WitrynaAbout us. Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet … shutterfly cyber monday saleWitrynaImpel NeuroPharma. Sep 2024 - Present1 year 8 months. Salt Lake City, Utah, United States. Launch of a new migraine product with Impel, I cover the greater SLC territory and north up to Idaho ... the paint postWitryna5 maj 2024 · Impel NeuroPharma, Inc., is a privately held, Seattle-based biopharmaceutical company which, based on the research of its founder, Chief … the paint post sheridanWitryna11 kwi 2024 · Corporate Profile. Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules … shutterfly cyber monday deals 2022WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … shutterfly deals 2021WitrynaIMPEL NEUROPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware : 26-3058238 (State or other jurisdiction of ... (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) 2024 Equity Incentive Plan . 2024 Employee Stock Purchase Plan . 2024 Equity Incentive ... shutterfly days of dealsWitrynaSenior Scientist. Impel NeuroPharma. Feb 2024 - Present1 year 2 months. Seattle. Oversee analytical method development, transfer … shutterfly deals